Press Release
TGaS Advisors Offers Collaborative Benchmarking Services for Pharmaceutical Companies
Ambler, Penn., April 24, 2007 — TGaS® Advisors, specialists in benchmarking pharmaceutical and biopharmaceutical commercial operations, has launched the PHARMASTANCE® family of benchmarks. These collaborative peer-set benchmarks enable clients to answer the question, “How do other pharmaceutical companies do ‘it’?®”. According to TGaS Managing Partner Stephen Gerard, the idea for the business evolved from this deceptively simple query he heard over and over again from his pharmaceutical colleagues.
“Answering that question became our mission,” said Gerard, whose partners include industry veterans Martin Driscoll and James Mercante. “TGaS was launched to provide clients with customized benchmark data and insights they can use to evaluate their own operational practices, resource allocations, processes and organizational structures in comparison with their peers.” Gerard said that company-specific data remain confidential and are shared only with the company itself.
PHARMASTANCE comprises the following benchmarks:
- Sales Operations Practices (SOPs)
- Specialty Sales Operations Practices (SSOPs)
- District Manager Operations Practices (DMOPs)
- Marketing Operations Practices (MOPs)
- Marketing Sciences Operations Practices (MSOPs)
- Managed Markets Operations Practices (MMOPs)
- Internet Marketing Operations Practices (iMOPs)
“In a changing pharmaceutical marketplace, we saw a need for a more collaborative peer-set model capable of providing fact-based insights to pharmaceutical executives,” said Gerard. “From small startup biopharmaceutical firms to multinational pharma conglomerates, everyone is facing similar challenges.” TGaS currently works with 23 of the top 35 pharma global companies, including four of the top five based in the U.S.
How PHARMASTANCE Works
PHARMASTANCE uses a proprietary methodology involving thorough information-gathering and extensive, in-depth personal interviews conducted by professionals with extensive experience in the industry. Using the collected information, TGaS creates a blinded, confidential, comprehensive dataset and then communicates the findings, insights and recommendations exclusively to the companies in the peer-set. Unlike traditional consulting companies or data providers, TGaS does not offer any ancillary services nor does it syndicate its data. TGaS presents the unbiased results to each individual company and makes implementation recommendations based on this information.
TGaS does not present its findings to clients as isolated facts but in the context of the entire operational “ecosystem,” indicating the impact different aspects have on each other. For example, clients can learn budgets for the average sales operations unit, but then understand at a deeper level how these budgets affect individual strategies and resource allocations within this ecosystem.
Why Benchmark?
As a time-tested and powerful management tool, benchmarking allows companies to evaluate various aspects of their businesses in relation to best practices. In addition to learning how their operations or brands compare to the blinded, aggregated benchmark data collected from companies participating in the dataset, Gerard said TGaS clients often use benchmarking to evaluate strategic advantages or disadvantages in their own operations, measure the performance of operations groups, justify current resource investments, adjust annual operating plans and reorganize for the future. In fact, he said, many TGaS clients are building benchmarking into their ongoing business processes to support continuous improvement.
About TGaS Advisors LLC
TGaS® Advisors was founded in 2003 by industry professionals, each with more than 20 years of pharmaceutical experience. TGaS provides the only comprehensive benchmark solutions for improving the strategy and effectiveness of pharmaceutical and biopharmaceutical operations. Because TGaS offers advisory services only, clients can evaluate options based solely on their business needs. TGaS Advisors is based in Ambler, Pennsylvania, with an office in Princeton, N.J. To learn more about TGaS, visit www.tgasadvisors.com or contact Stephen Gerard at sgerard@tgasadvisors.com.
- Other Press Releases:
- Record Number of Pharma Operations Leaders Share Challenges, Solutions at Four TGaS Advisors Forums
- “Turning Prophets into Strategists and Leaders” Seen as Opportunity for Market Research; Theme of Pharma Market Research Group Presentation
- TGaS Advisors Named to Philadelphia 100®, Ranked 18th Among Region’s Fastest Growing Privately Held Companies
- Sharon Patent Appointed Director, Marketing Sciences Operations Practices, at TGaS Advisors, Adding New Dimension to Analytics Capabilities
- Top Pharma Execs Discuss Regionalization and Outsourcing Trends at TGaS® Advisors Operations Forum
- TGaS Advisors Launches Internet Performance Benchmark
- TGaS Advisors’ Gerard Moderates Featured Panel at CBI Pharma Leadership Summit on Impact of Innovation on Sales Operations
- TGaS Advisors’ Castello Offers Advice on Managing Changes in Pharma Sales Compensation Plans
- TGaS Advisors Named to 2008 Inc. 500
- TGaS Advisors Leader Steve Gerard Named One of “100 Most Inspiring People” by PharmaVoice Magazine
- TGaS Advisors Launches Organization and Career Guide Benchmark for Pharma Sales Operations
- TGaS Advisors Appoints James P. Castello Director, Management Advisor
- TGaS Advisors Named as Finalists In 2008 American Business Awards
- TGaS Advisors Hires Brian Bamberger to Spearhead Managed Markets Benchmarks
- Pharma Marketing Sciences Execs Learn “How Other Companies Do It” at TGaS Advisors Client Forum
- TGaS Advisors’ Wojcik Analyzes Incentive Compensation Issues at Pharma Sales Force Performance Conference
- TGaS Advisors Expands Executive Ranks to Accommodate Business Growth; Pharma Veteran John P. Carro Joins as Vice President, Management Advisor
- TGaS Advisors TGaS Advisors Creates New Position to Accommodate Business Growth; Pharma Veteran Tom Bang Joins as Executive in Residence
- TGaS Advisors Creates New Position; Pharma Veteran Gary McWalters Joins as Director of Marketing and Business Development
- TGaS Advisors Expands Staff to Accommodate Business Growth Robert Shewbrooks Joins Firm as Vice President, Management Advisor
- TGaS Advisors Appoints Boucher to New Analytics, Outreach Position
- TGaS Advisors Moves into New Corporate Headquarters
- TGaS Advisors Launches Compliance Operations Benchmark (COPs)
- TGaS Advisors Hires Jeff Wojcik and Donna Wray